✦ LIBER ✦

A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia

✍ Scribed by Joseph P. McEvoy; David G. Daniel; William H. Carson Jr.; Robert D. McQuade; Ronald N. Marcus

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of the Efficacy and Safety of

✍ Hartmut Porst; François Giuliano; Sidney Glina; David Ralph; Adolfo R. Casabé; A 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 396 KB

Efficacy and safety of bifeprunox in pat

✍ Daniel E. Casey; Earl E. Sands; Jens Heisterberg; Hwa-Ming Yang 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 291 KB

Efficacy and safety of bisacodyl in the

✍ S. KIENZLE-HORN; J.-M. VIX; C. SCHUIJT; H. PEIL; C. C. JORDAN; M. A. KAMM 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

Efficacy and safety of bilastine 20 mg c

✍ P. Kuna; C. Bachert; Z. Nowacki; P. Van Cauwenberge; I. Agache; L. Fouquert; A. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

Intramuscular aripiprazole for the treat

✍ Raisa Andrezina; Richard C. Josiassen; Ronald N. Marcus; Dan A. Oren; George Man 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 262 KB

A randomized placebo-controlled trial co

✍ A. Puopolo; J.A. Boice; J.L. Fidelholtz; T.W. Littlejohn; P. Miranda; A. Berroca 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 218 KB

A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20&#xa0;mg/day for the treatment of patients with acute exacerbations of schizophrenia